Search

Your search keyword '"Alu, Maria C."' showing total 267 results

Search Constraints

Start Over You searched for: Author "Alu, Maria C." Remove constraint Author: "Alu, Maria C."
267 results on '"Alu, Maria C."'

Search Results

1. Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD

5. Patient-Prosthesis Mismatch After Surgical Aortic Valve Replacement: Analysis of the PARTNER Trials

6. Changes in Left Ventricular Function and Outcomes After Trancatheter Edge-to-Edge Repair for Secondary Mitral Regurgitation

8. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

9. Minimum Core Data Elements for Transcatheter Mitral Therapies: Scientific Statement by PASSION CV, HVC, and TVTR

11. Severity of and Recovery From Anemia After Transcatheter Aortic Valve Replacement: An Analysis of the PARTNER Trials and Registries

12. Minimally Invasive Versus Full Sternotomy for Isolated Aortic Valve Replacement in Low-Risk Patients

13. Minimum Core Data Elements for Evaluation of TAVR: A Scientific Statement by PASSION CV, HVC, and TVT Registry

15. Left Ventricular Global Longitudinal Strain as a Predictor of Outcomes in Patients with Heart Failure with Secondary Mitral Regurgitation: The COAPT Trial

16. Atrial Fibrillation and Outcomes After Transcatheter or Surgical Aortic Valve Replacement (from the PARTNER 3 Trial)

17. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries

20. Left and right ventricular longitudinal systolic function following aortic valve replacement in the PARTNER 2 trial and registry.

24. Outcomes in 937 Intermediate-Risk Patients Undergoing Surgical Aortic Valve Replacement in PARTNER-2A

25. Sex-Specific Outcomes of Transcatheter Aortic Valve Replacement With the SAPIEN 3 Valve: Insights From the PARTNER II S3 High-Risk and Intermediate-Risk Cohorts

26. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

27. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

28. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial

29. CT-Defined Prosthesis–Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement

30. Outcome of Flow-Gradient Patterns of Aortic Stenosis After Aortic Valve Replacement: An Analysis of the PARTNER 2 Trial and Registry

31. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial

32. Diastolic Dysfunction and Health Status Outcomes After Transcatheter Aortic Valve Replacement

33. Changes in Left Ventricular Global Longitudinal Strain in Patients With Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial

34. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis

36. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials

37. Impact of right ventricle-pulmonary artery coupling on clinical outcomes in the PARTNER 3 trial

38. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints

40. Cardiac Damage and Quality of Life After Aortic Valve Replacement in the PARTNER Trials

41. Impact of Right Ventricle-Pulmonary Artery Coupling on Clinical Outcomes in the PARTNER 3 Trial

42. Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes

43. Evolution and Prognostic Impact of Cardiac Damage After Aortic Valve Replacement

44. Minimum Core Data Elements for Evaluation of TAVR

45. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

46. Characteristics and clinical outcomes in patients with prior chest radiation undergoing TAVR: Observations from PARTNER‐2

47. Impact of Predilation During Transcatheter Aortic Valve Replacement: Insights From the PARTNER 3 Trial

48. Valve Academic Research Consortium 3:Updated endpoint definitions for aortic valve clinical research

49. Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research

50. Outcomes 2 Years After Transcatheter Aortic Valve Replacement in Patients at Low Surgical Risk

Catalog

Books, media, physical & digital resources